CAXTON CORP XERS Holdings History

Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$7.52 Mil
% of Total Estimate Gain
55.19%

CAXTON CORP's Xeris Biopharma Holdings Inc Holding Summary

As of 2025-03-31, CAXTON CORP held - shares of Xeris Biopharma Holdings Inc(XERS), totaling N/A. This investment constitutes 0% of their stock portfolio, and CAXTON CORP now holds 0% of the outstanding Xeris Biopharma Holdings Inc(XERS) stock.

The initial trade took place in 2021Q4. And since then CAXTON CORP has made 1 purchases of XERS, at an average price of $2.16, for a total of 6.31 Mil shares. In addition, there have been 5 sales at an average price of $3.35 for 6.31 Mil shares. Based on historical transaction data and XERS's current price of $4.70, CAXTON CORP's estimated gain on his XERS holdings is $7.52 Mil, reflecting a 55.19% gain to date.

CAXTON CORP XERS ($4.70) Holding Chart

CAXTON CORP XERS ($4.70) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1